Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014351 |
---|---|
Receipt number | R000016703 |
Scientific Title | Phase II Neoadjuvant Study of EC followed by Abraxane in opetable breast cancer. |
Date of disclosure of the study information | 2014/06/24 |
Last modified on | 2018/11/19 15:34:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/23 16:13:18 | ||
2 | Update | 2016/02/19 11:05:20 | Recruitment status |
|
3 | Update | 2016/02/19 11:09:16 | Organization Organization Category of Funding Organization |
|
4 | Update | 2016/11/07 09:22:57 | Name of primary person or sponsor Organization |
|
5 | Update | 2018/11/19 15:34:39 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |